To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Comparing Two Different Corticosteroid Injection Locations for Adhesive Capsulitis

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
November 2022

Comparing Two Different Corticosteroid Injection Locations for Adhesive Capsulitis

Vol: 302| Issue: 3| Number:2| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison Between Corticosteroid Injection Into Coracohumeral Ligament and Inferior Glenohumeral Capsule and Corticosteroid Injection Into Posterior Glenohumeral Recess in Adhesive Capsulitis: A Prospective Randomized Trial

Pain Physician. 2022 Sep;25(6):E787-E793.

Contributing Authors:
SH Lee HH Choi MC Chang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and twenty patients with adhesive capsulitis were randomized to receive up to 3 weekly corticosteroid injections into the coracohumeral ligament and inferior glenohumeral capsule (CHL + IGHC; n=60) or via the posterior glenohumeral recess (PGHR; n=60). The outcomes of interest included pain intensity on a Visual Analog Scale (VAS) and passive shoulder range of motion in abduction; exte...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue